Martin Vazquez - Jul 1, 2021 Form 4 Insider Report for Outset Medical, Inc. (OM)

Role
Chief Operating Officer
Signature
By: John L Brottem For: Martin Vazquez
Stock symbol
OM
Transactions as of
Jul 1, 2021
Transactions value $
-$725,843
Form type
4
Date filed
7/2/2021, 04:37 PM
Previous filing
Jun 2, 2021
Next filing
Aug 3, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OM Common Stock Options Exercise $23.3K +6K +64.83% $3.88* 15.3K Jul 1, 2021 Direct
transaction OM Common Stock Sale -$295K -6K -39.33% $49.24 9.26K Jul 1, 2021 Direct F1, F2
transaction OM Common Stock Options Exercise $19.4K +5K +54.02% $3.88* 14.3K Jul 1, 2021 Direct
transaction OM Common Stock Sale -$246K -5K -35.08% $49.26 9.26K Jul 1, 2021 Direct F1, F3
transaction OM Common Stock Options Exercise $19.4K +5K +54.02% $3.88* 14.3K Jul 1, 2021 Direct
transaction OM Common Stock Sale -$246K -5K -35.08% $49.24 9.26K Jul 1, 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OM Non-Qualified Stock Option (right to buy) Options Exercise $0 -6K -7.1% $0.00 78.5K Jul 1, 2021 Common Stock 6K $3.88 Direct F4
transaction OM Non-Qualified Stock Option (right to buy) Options Exercise $0 -5K -6.37% $0.00 73.5K Jul 1, 2021 Common Stock 5K $3.88 Direct F4
transaction OM Non-Qualified Stock Option (right to buy) Options Exercise $0 -5K -6.8% $0.00 68.5K Jul 1, 2021 Common Stock 5K $3.88 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 14. 2020.
F2 The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $48.65 to $50.27, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $48.65 to $50.49, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 This option vests 25% on October 9, 2018 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.